We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Cate Speake PhD

Cate Speake PhD

Research Assistant Member and Science Director, Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington

Cate Speake, PhD, is a Research Assistant Member at the Benaroya Research Institute at Virginia Mason (BRI) and Scientific Director of the BRI Center for Interventional Immunology.  Her work has focused on the identification of biomarkers that predict type 1 diabetes disease progression.  She leads BRI’s Experimental Medicine Unit, which conducts small clinical trials to investigate the mechanistic drivers of type 1 diabetes.  With Dr. Jane Buckner, she co-leads the Sound Life Project, aiming to better understand the functional breadth of the healthy immune system. Dr. Speake’s focus is on translating findings in the laboratory to the clinic, using her expertise in analyzing large data sets to help answer clinical questions, from initial work in infectious disease settings to her current work in diabetes and autoimmunity.  


Dr, Speake has no relevant disclosures.